Acquired Brain Injury — Approach to Sexuality From Occupational Therapy in People With Acquired Brain Injury in Subacute Stage
Citation(s)
Brunsden C, Kiemle G, Mullin S Male partner experiences of females with an acquired brain injury: An interpretative phenomenological analysis. Neuropsychol Rehabil. 2017 Sep;27(6):937-958. doi: 10.1080/09602011.2015.1109525. Epub 2015 Nov 26.
Hyland A, Mc Grath M Sexuality and occupational therapy in Ireland--a case of ambivalence? Disabil Rehabil. 2013 Jan;35(1):73-80. doi: 10.3109/09638288.2012.688920. Epub 2012 Jun 2.
McGrath M, Lynch E Occupational therapists' perspectives on addressing sexual concerns of older adults in the context of rehabilitation. Disabil Rehabil. 2014;36(8):651-7. doi: 10.3109/09638288.2013.805823. Epub 2013 Jun 26.
Schmitz MA, Finkelstein M Perspectives on poststroke sexual issues and rehabilitation needs. Top Stroke Rehabil. 2010 May-Jun;17(3):204-13. doi: 10.1310/tsr1703-204.
Townsend E, Wilcock AA Occupational justice and client-centred practice: a dialogue in progress. Can J Occup Ther. 2004 Apr;71(2):75-87. Review.
Approach to Sexuality From Occupational Therapy in People With Acquired Bran Injury in Subacute Stage
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
